Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Other Working Capital

Cash effect of changes in other operating assets and liabilities.

No reported Other Working Capital figures are available to summarize.

Other Working Capital history

Currency unavailable · from the cash flow

No Other Working Capital data reported for this period type.

Other Working Capital vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors
Other Working Capital for KARD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TNYATenaya Therapeutics, Inc.LTM Mar 2026$9.53M USD+273.5%-25.8%4237.3%
CYTKCytokinetics, IncorporatedLTM Jun 2026$9.23M USD+3157.3%-24.4%13.0%
NAMSNewAmsterdam Pharma Company N.V.LTM Jun 2026$4.99M USD-76.8%-64.8%70.1%
RNAAtrium Therapeutics, Inc.FY2025$3.93M USD——21.1%
IKTInhibikase Therapeutics, Inc.LTM Mar 2026$1.22M USD-461.4%——
KARDKardigan, Inc.—— ———
Peer median (excluding KARD) —+98.3%-25.8%45.6%

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.